Small molecule | ApexOnco - Clinical Trials news and analysis

“The insights provided by the analysts are great”

Director New Product Planning

Morphosys

Click here for more information

Regulatory

14 May 2026

BeOne bags its first next-gen approval

Regulatory Trial results

6 May 2026

Ideaya exits Werner and Pol theta

Ideaya discontinues IDE275 and IDE705, previously ditched by GSK.

Trial results

6 May 2026

Exelixis slips out a zanzalintinib delay

Regulatory Trial results

30 April 2026

Krazati's colorectal cancer approval in jeopardy

Deals

28 April 2026

Lilly aims to clean up in JAK inhibition

Data insights

23 April 2026

Toxicity doesn't stop Incyte

The company has started a pivotal trial of its KRAS G12D inhibitor in pancreatic cancer.

Conferences Trial results

20 April 2026

AACR 2026 – Revolution’s second project impresses again

Data insights

17 April 2026

Pfizer backs a new mechanism

Data insights

27 March 2026

Revolution's first-line bet starts recruiting

Regulatory

26 March 2026

Approval completes Corcept's turnaround

Subscribe to Small molecule

BeOne bags its first next-gen approval

Ideaya exits Werner and Pol theta

Exelixis slips out a zanzalintinib delay

Krazati's colorectal cancer approval in jeopardy

Lilly aims to clean up in JAK inhibition

Toxicity doesn't stop Incyte

AACR 2026 – Revolution’s second project impresses again

Pfizer backs a new mechanism

Revolution's first-line bet starts recruiting

Approval completes Corcept's turnaround

Recent Quick take

Most Popular